Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction.
Market Cap | 8.327 Million | Shares Outstanding | 28.517 Million | Avg 30-day Volume | 105.479 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.49 |
Price to Revenue | 0.0 | Debt to Equity | 0.3514 | EBITDA | -12.731 Million |
Price to Book Value | 6.9318 | Operating Margin | 0.0 | Enterprise Value | 8.174 Million |
Current Ratio | 1.649 | EPS Growth | 0 | Quick Ratio | 1.286 |
1 Yr BETA | 0.6456 | 52-week High/Low | 2.08 / 0.2 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 5.298 | Altman Z-Score | -31.9193 | Free Cash Flow to Firm | -9.972 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
CLAIBORNE CARY J CHIEF EXECUTIVE OFFICER |
|
1,520,000 | 2023-05-23 | 3 |
|
0 | 2023-05-23 | 2 | |
|
0 | 2023-05-23 | 1 | |
|
1,261,779 | 2023-05-23 | 3 | |
TRULUCK JOSEPH CHIEF FINANCIAL OFFICER |
|
265,139 | 2023-05-23 | 1 |
|
0 | 2023-05-23 | 1 | |
|
0 | 2023-05-23 | 1 | |
|
0 | 2023-05-23 | 1 | |
|
0 | 2023-05-23 | 1 | |
|
0 | 2020-05-19 | 0 | |
|
1,467,420 | 2018-07-31 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLAIBORNE CARY J - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-05-25 16:36:03 -0400 | 2023-05-23 | A | 300,000 | a | 300,000 | direct | |||||||||
CLAIBORNE CARY J - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-05-25 16:36:03 -0400 | 2023-05-23 | A | 420,000 | a | 1,520,000 | direct | 0.3636 | 5.4545 | 5.4545 | 6 | -4.3636 | 3 | |||
2023-05-25 16:34:24 -0400 | 2023-05-23 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-05-25 16:41:22 -0400 | 2023-05-23 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-05-25 16:38:50 -0400 | 2023-05-23 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-05-25 16:43:30 -0400 | 2023-05-23 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-05-25 16:47:59 -0400 | 2023-05-23 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-05-25 16:47:59 -0400 | 2023-05-23 | A | 240,800 | a | 1,261,779 | direct | 0.3636 | 5.4545 | 5.4545 | 6 | -4.3636 | 3 | ||||
2023-05-25 16:45:28 -0400 | 2023-05-23 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-05-25 16:50:18 -0400 | 2023-05-23 | A | 125,000 | a | 125,000 | direct | ||||||||||
2023-05-25 16:50:18 -0400 | 2023-05-23 | A | 157,500 | a | 265,139 | direct | 0.3636 | 5.4545 | 5.4545 | 6 | -4.3636 | 3 | ||||
2023-06-02 07:52:35 -0400 | 2023-05-23 | A | 40,000 | a | 40,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 22:15:04 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 21:45:05 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 21:15:04 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 20:45:04 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 20:15:06 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 19:45:04 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 19:15:04 UTC | -1.6365 | 6.7065 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 18:45:04 UTC | -1.6356 | 6.7056 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 18:15:03 UTC | -1.6356 | 6.7056 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 17:45:05 UTC | -1.6356 | 6.7056 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 17:15:04 UTC | -1.6356 | 6.7056 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 16:45:03 UTC | -1.4974 | 6.5674 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 16:15:04 UTC | -1.4974 | 6.5674 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 15:45:04 UTC | -1.4974 | 6.5674 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 15:15:04 UTC | -1.4974 | 6.5674 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 14:45:04 UTC | -1.4974 | 6.5674 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 14:15:03 UTC | -1.4974 | 6.5674 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 13:45:03 UTC | -1.7721 | 6.8421 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 13:15:04 UTC | -1.7721 | 6.8421 | 350000 |
ADIAL PHARMACEUTICALS INC ADIL | 2023-06-07 12:45:04 UTC | -1.7721 | 6.8421 | 350000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | ADIL | -1600.0 shares, $-560.0 | 2023-03-31 | N-PORT |